Shanghai Zhongke Xinxing Biological Technology

Shanghai Zhongke Xinxing Biological Technology is a Chinese biotechnology company focused on the development and industrialization of stem cell therapies and regenerative medicine. Established with significant backing and technical support from the Chinese Academy of Sciences (CAS), the company serves as a commercial vehicle for translating advanced stem cell research into clinical applications. Their primary focus includes the development of standardized mesenchymal stem cell products derived from umbilical cord and other tissues. The company targets high-unmet-need areas such as chronic liver disease, metabolic disorders, and autoimmune conditions. Based in Shanghai, they operate specialized R&D and manufacturing facilities designed to meet clinical-grade cell production standards.